Phase 3 Readout~month

Phase 3 Topline: Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Nec

Indication
Acute Renal Failure (ARF); Acute Tubular Necrosis

Other upcoming events for VALN

Phase 2 StartPhase 2 Start: Double-blind, Prospective, Randomized, Placebo-controlled Trial to Assess if Activin Ligand-trap Bio
Phase 2 StartPhase 2 Start: A Two Cohort, Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-Center Signal-Finding Stu
Phase 3 ReadoutPhase 3 Topline: A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Ex
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Open-label, Controlled Study to Investigate the Efficacy and Saf
Phase 3 ReadoutPhase 3 Topline: NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis: A Randomized, Controlle

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Nec — VALN Phase 3 Readout | BioSniper